Effectiveness and Safety of Ivermectin in COVID-19 Patients: A Prospective Study at A Safety-Net Hospital
Conclusion: No differences were found between groups regarding the length of hospital stay, ICU admission, intubation rate, and in-hospital mortality.
Ivermectin has been found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. It is unknown whether this inhibition of SARS-CoV-2 replication correlates with improved clinical outcomes. To assess the effectiveness and safety of ivermectin in hospitalized...
pubmed.ncbi.nlm.nih.gov